Molecular Correlates of Cisplatin-based Chemotherapy Response in Muscle Invasive Bladder Cancer by Integrated Multi-omics Analysis

被引：0
|
作者：
Taber, A. [1 ]
Christensen, E. [1 ]
Lamy, P. [1 ]
Nordentoft, I [1 ]
Prip, F. F. [1 ]
Lindskrog, C., V [1 ]
Birkenkamp-Demtroder, K. [1 ]
Okholm, T. L. H. [1 ]
Knudsen, M. [1 ]
Pedersen, J. S. [1 ]
Steiniche, T. [1 ]
Agerboek, M. [1 ]
Jensen, J. B. [1 ]
Dyrskjot, L. [1 ]
机构：
[1] Aarhus Univ Hosp, Dept Mol Med MOMA, Aarhus, Denmark
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2020年 / 38卷 / 12期
关键词：
D O I：
10.1016/j.urolonc.2020.10.031
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：899 / 899
页数：1
相关论文
共 50 条
  • [41] A study of split-dose cisplatin-based neo-adjuvant chemotherapy in muscle-invasive bladder cancer
    Hussain, S. A.
    Palmer, D. H.
    Lloyd, B.
    Collins, S. I.
    Barton, D.
    Ansari, J.
    James, N. D.
    ONCOLOGY LETTERS, 2012, 3 (04) : 855 - 859
  • [42] Efficacy of Split Schedule Versus Conventional Schedule Neoadjuvant Cisplatin-Based Chemotherapy for Muscle-Invasive Bladder Cancer
    Osterman, Chelsea K.
    Babu, Dilip S.
    Geynisman, Daniel M.
    Lewis, Bianca
    Somer, Robert A.
    Balar, Arjun V.
    Zibelman, Matthew R.
    Guancial, Elizabeth A.
    Antinori, Gianna
    Yu, Shun
    Narayan, Vivek
    Guzzo, Thomas J.
    Plimack, Elizabeth R.
    Vaughn, David J.
    Fung, Chunkit
    Mamtani, Ronac
    ONCOLOGIST, 2019, 24 (05): : 688 - 690
  • [43] Defining molecular and laboratory predictive biomarkers of response to cisplatin-based neoadjuvant chemotherapy (NC) in muscle-invasive bladder cancer (MIBC) - preliminary results and future plans
    Leibowitz-Amit, Raya
    Seah, Jo-An
    Berger, Raanan
    Sridhar, Srikala S.
    CANCER RESEARCH, 2014, 74 (19)
  • [44] Forty years of cisplatin-based chemotherapy in muscle-invasive bladder cancer: are we understanding how, who and when?
    Julian Schardt
    Beat Roth
    Roland Seiler
    World Journal of Urology, 2019, 37 : 1759 - 1765
  • [45] Impact of intra-tumoral immunity on predicting response and survival after neoadjuvant cisplatin-based chemotherapy in patients with muscle invasive bladder cancer
    Mendoza-Valderrey, Alberto
    Choe, Jane
    Kessler, Daria M.
    Jimenez, Gianna
    Li, Xinmin
    Kolker, Steven
    Allen, Warren
    Linehan, Jennifer A.
    Twardowski, Przemyslaw W.
    Ascierto, Maria Libera
    CANCER MEDICINE, 2024, 13 (15):
  • [46] Molecular determinants of response to cisplatin-based neoadjuvant chemotherapy
    Bellmunt, Joaquim
    Pons, Francesc
    Orsola, Anna
    CURRENT OPINION IN UROLOGY, 2013, 23 (05) : 466 - 471
  • [47] Immune correlates of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer
    Ginwala, Rashida
    Macfarlane, Alexander
    Liu, David
    Alpaugh, R. K.
    Xiu, Joanne
    Gatalica, Zoran
    Korn, W. M.
    Van Allen, Eliezer M.
    Campbell, Kerry S.
    Kutikov, Alexander
    Plimack, Elizabeth
    Abbosh, Philip H.
    CANCER RESEARCH, 2020, 80 (16)
  • [48] ACCELERATED CISPLATIN-BASED CHEMOTHERAPY FOR ADVANCED BLADDER-CANCER
    BOSHOFF, C
    OLIVER, RTD
    GALLAGHER, CJ
    ONG, J
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (10) : 1633 - 1636
  • [49] Predictive value of phenotypic signatures of bladder cancer response to cisplatin-based neoadjuvant chemotherapy
    Hensley, Patrick J.
    Kyprianou, Natasha
    Purdom, Matthew S.
    He, Daheng
    DiCarlo, Vincent
    Wang, Chi
    James, Andrew C.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (09) : 572.e1 - 572.e11
  • [50] Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer
    Gil Jimenez, Albert
    van Dorp, Jeroen
    Contreras-Sanz, Alberto
    van der Vos, Kristan
    Vis, Daniel J.
    Braaf, Linde
    Broeks, Annegien
    Kerkhoven, Ron
    van Kessel, Kim E. M.
    Ribal, Maria Jose
    Alcaraz, Antonio
    Wessels, Lodewyk F. A.
    Seiler, Roland
    Wright, Jonathan L.
    Mengual, Lourdes
    Boormans, Joost
    van Rhijn, Bas W. G.
    Black, Peter C.
    van der Heijden, Michiel S.
    EUROPEAN UROLOGY, 2023, 83 (04) : 313 - 317
12345